Log In
Print this Print this

BiDil XR

  Manage Alerts
Collapse Summary General Information
Company Deerfield Management Co. L.P.
DescriptionOral, extended-release formulation of hydralazine hydrochloride and isosorbide dinitrate
Molecular Target Not available
Mechanism of ActionNA
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPilot
Standard IndicationHeart failure
Indication DetailsTreat heart failure in African American patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today